chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At approximately 6:30pm on August 30, 2021 the heart pain began.  It can be best described as a constant squeezing/crushing pain with a strong "stabbing" pain happening  a few times each day. This has persisted everyday since August 30, 2021. On August 6, 2021, I was sent to the e.r. where they performed an ekg and blood tests. The results for my Troponin 1 (high sensitivity) test at the time were <3.0 pg/mL.  The attending doctor recommended that I see my primary care physician. I went back to the E.R. on September 11, 2021 due to the increase in severity of the heart/chest pain. An ekg was performed, but the attending doctor refused to take another blood sample to test, even after I specifically requested one. Today the pain still persists.
This spontaneous report as received from a physician via a company representative refers to a 52 year old female patient. The patient's concurrent condition included pre-leukemia and was under the care of a hematologist. The patient had drug reactions/allergies to several antibodies. On 06-SEP-2016, the patient was vaccinated with PNEUMOVAX 23 (lot # L035687 expiry date: 16-FEB-2016) (dose and route were not reported). Information on concomitant medication was not known by reporter. On 06-SEP-2016, the patient developed infection in her vaccinated arm, she experienced high fever, redness on the arm and developed a bacterial infection which could be from possibly a contaminated vial. The physician reported that the patient went testing at the emergency room (ER). The physician reported that he had never seen anything like this in his years of practice and stated that the patients white blood cell count elevated from normal 10800 to 30000 (units not provided) which indicated that it was a very serious infection. The physician requested to have the vaccine lot checked further. The patient sought medical attention and was hospitalized at an unspecified hospital on an unspecified date. The patient received unspecified treatment for the adverse events. Lab diagnostic test included blood count and culture test (result not reported). It was reported that the patient was discharged from the hospital on an unspecified date and was doing okay (outcome considered as recovering). The causality assessment was not reported. No further information provided. Additional information has been requested.
Muscle spasms; Twitching on her left side of her face, near her left eyelid.; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Muscle spasms) and MUSCLE TWITCHING (Twitching on her left side of her face, near her left eyelid.) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 011J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided) on 15-Jan-2021.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced MUSCLE SPASMS (Muscle spasms) and MUSCLE TWITCHING (Twitching on her left side of her face, near her left eyelid.). At the time of the report, MUSCLE SPASMS (Muscle spasms) and MUSCLE TWITCHING (Twitching on her left side of her face, near her left eyelid.) outcome was unknown.            no concomitant medication provided no treatment taken
Abdominal pain, centered and slightly left side.  Intermittent beginning afternoon of 10/1/21.  Continuous and increasing afternoon of 10/2/21 and severe from 11pm 10/2/21 though time of visit to ER on 10/3/2021.  Treated with Dilaudid for pain.  Given prescription for Ondansetron, 4mg tid.  Symptoms did not reoccur after discharge.
approx 5 mins p/vax pt c/o intense itching condition rapidly intensified; given epi followed by DPH; pt hypotensive & for a bried period unresponsive; Epi repeated x 2 @ 5 mins;
improperly stored vaccine was administered to a consumer; This spontaneous report was received from a nurse, referring to a 5-year-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, previous drug allergies or reactions and concomitant medications were not reported.  On 14-SEP-2020, the patient was vaccinated with improperly stored dose of  measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, lot # S005249 was confirmed to be valid, expiration date 20-FEB-2021 (albumin status rHA) (exact dose, route of administration and anatomical location were not provided).  The temperature excursions were above 47 degrees Fahrenheit (F) (48.38 F) for 55 minutes, and above 47 degrees Fahrenheit (F) (54.32 F) for 7 hours and 14 minutes. There were no previous excursions reported. The digital data logger was involved.
left armpit/chest pain, kind of where the lymph nodes are; left armpit/chest pain , kind of where the lymph nodes are; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 31Aug2021 16:30 (Lot number: fd8448) at the age of 35 years as dose 1, single and administered in arm right, administration date 20Sep2021 16:30 (Lot number: fd8448) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: CHEST PAIN (non-serious) with onset Sep2021, outcome "not recovered", described as "left armpit/chest pain, kind of where the lymph nodes are"; AXILLARY PAIN (non-serious) with onset Sep2021, outcome "not recovered", described as "left armpit/chest pain , kind of where the lymph nodes are". Therapeutic measures were not taken as a result of chest pain, axillary pain.  Additional information: The patient did not have covid prior vaccination. The patient did not get covid tested post vaccination. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported left armpit/chest pain, kind of where the lymph nodes are. Almost constant, goes away when he squeeze or apply pressure in that area.  No follow-up attempts are possible. No further information is expected.
After getting the vaccine, I felt very nauseous for two days. And then red rashes started from arms, and very  itch, that I thought they were bug bites. But the rashes spread legs, back, and torso which were extremely itch that I could not sleep well.  I bought Benadril and Cortisol but they did not work, so I went to the  Pharmacy where the vaccine shot had provided to me yesterday to report this side effect. I report the side effect to them, but I dont think they report this to CDC that I am writing to you now.   I went to the doctor office today and got the medicine for allergy.
Achey; Fever; Left arm sore for a weak; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achey), PYREXIA (Fever) and VACCINATION SITE PAIN (Left arm sore for a weak) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN (Achey), PYREXIA (Fever) and VACCINATION SITE PAIN (Left arm sore for a weak). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 02-Mar-2021, PAIN (Achey) and PYREXIA (Fever) had resolved. On 08-Mar-2021, VACCINATION SITE PAIN (Left arm sore for a weak) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
The injection itself was incredibly painful.  The nurse giving the injection asked why they were given extra long needles and then asked if I'd like to see it.  I said, "Yes."  I joked and said it looked like it was more likely for the ass than the arm.  She laughed and proceeded to inject me.  The injection was the most painful I had ever felt.  The next morning, I awoke with pain in my shoulder, neck and back.  Though I expected some reaction to the vaccine, I didn't expect the amount of pain and discomfort I experienced.  It has continued in large part to the present.  I sought medical advice towards the end of the first week.  Eventually, I received an MRI which suggested myelitis/discitis.  Of course, the MRI was more detailed.    I was subsequently hospitalized for four days where I had numerous blood cultures and another MRI (cervical and thoracic w/and without contract).  The MRI essentially had the same findings.  The doctors are stymied by my history and symptoms.  However,  given the temporal proximity between the time of the injection and the onset of my pain/symptoms (that has yet to resolve), I think it important to report this matter.  I am still is pain and my issues have not resolved.
Four hours after HPV mother stated child developed throat irritation, shortness of breath. Next day chest discomfort.
itchy eyes; Sensitivity to strong odors; unstoppable sneezing; continuous runny nose; This is a spontaneous report from a non-contactable consumer (patient). A 41-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 04Apr2021 at 12:00 (at the age of 41-years-old) as dose 2, single for COVID-19 immunization. Medical history included hypothyroidism from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. There were no known allergies. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 25Mar2021 at 08:45 as dose 1, single for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced itchy eyes, sensitivity to strong odors, unstoppable sneezing and continuous runny nose on 14Apr2021 12:00. The patient did not receive any treatment for the events. The clinical outcome for the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
COVID vaccine breakthrough case. Moderna 2/18/21 007M20A, 3/18/21 006B21A, 1/6/22 068H21A, 7/29/22 059M21A, and 1/20/23 bivalent 021H22A.
2nd Dose given from beyond use date vial; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (2nd Dose given from beyond use date vial) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (2nd Dose given from beyond use date vial). On 16-Jun-2021, EXPIRED PRODUCT ADMINISTERED (2nd Dose given from beyond use date vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No treatment medications were reported.
Cough; Can't breath; Super congested; Swollen face; Feel sick; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), DYSPNOEA (Can't breath), NASAL CONGESTION (Super congested), SWELLING FACE (Swollen face) and ILLNESS (Feel sick) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Codeine Allergy). Concomitant products included VALACICLOVIR HYDROCHLORIDE (VALTREX) for an unknown indication.    On 15-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jul-2021, the patient experienced COUGH (Cough), DYSPNOEA (Can't breath), NASAL CONGESTION (Super congested), SWELLING FACE (Swollen face) and ILLNESS (Feel sick). At the time of the report, COUGH (Cough), DYSPNOEA (Can't breath), NASAL CONGESTION (Super congested), SWELLING FACE (Swollen face) and ILLNESS (Feel sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information were reported.
Dizzy and throwing up; Dizzy and throwing up; Initial information received on 18-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer.  This case is linked to case 2020SA296074.  This case involves a patient who experienced dizzy and throwing up, while he/she received vaccine INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medications were unknown.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious dizzy and throwing up (dizziness and vomiting) (Unknown latency) following the administration of INFLUENZA VACCINE.  Final diagnosis was dizziness and vomiting.   Relevant laboratory data was not reported.  It was not reported if the patient received a corrective treatment.  The outcome was reported as Unknown for all events.  There will be no information available on the batch number for this case.
-24 hr later 104 fever, delirious (6hrs)  - TYLENOL - low grade x 4 days (TYLENOL) - localized rash arm chest 1 week - symptoms resolved after one week
Patient was given the 3rd dose for the Pfizer-COVID Booster prior to authorization from the CDC, FDA and Hospital. Patient did not sustain any adverse effects, symptoms, etc. Mistake was made aware of immediately to clinic manager and clinic supervisor, as well as PCP.
This spontaneous report was received from a nurse refers to 12-month-old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 30-AUG-2017, the patient was vaccinated with improperly stored M-M-R II (dosing details were not reported) (lot # M045392, expiry date: 17-NOV-2018) for prophylaxis. The lot of M-M-R II were reconstituted with properly stored sterile diluent (MRK). No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as from 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA000054: Original Case: 1709USA000054.
Patient received vaccination on 1/13/2021 ~11:30 AM, developed a rash to left breast the same day around 8 pm may have lasted an hour.  Applied Hydrocortisone and went to sleep before 9 pm.  Rash resolved.
I had chickenpox as a child, r,eceived Shingles vaccine 2012, Oct 13, 2021 symptoms of shingles began, received treatment  for shingle Oct 20,2021 Predinisone , Acyclovir, Pregablin, Gabapentin. Took last dose Acyclovir on,  Oct 30. Sore throat and congestion started Z pack 11/5. new lesions and exacerbation of old lesions began 11/6, started Valtrex 11/l. I believe the occurrence of Shingles, then  reoccurrence of Shingles immediately following a  full 10 day course of Acyclovir is related to the covid vaccine which I experienced side effects following the vaccine.
Day # 12 post immunization with 2 skin lesions. 1) - follicular on neck, throat, (R) arm. - itchy. Pictures sent to Dr., felt to be post-vaccinal non-viral pustulosis, symptoms improved with BENADRYL. 2) 1-2 cm nodular subcutaneous nodule x 4 on ear, (R) jaw line and neck, improving with BENADRYL, complement studies ordered. 3/3/09-records received for Dos 2/24/09-swelling and erythema left axillary LAD and malaise about 8-10 days after vaccine now C/O rashes distal to immunization site. Lesions itchy on neck, chest abdomen and right arm.
came down with shingles got the shots /suspected Vaccination failure; came down with shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. In June 2021, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The reporter was the patient. The patient got the shots with the dead virus in January and February. The patient's doctor said those who contracted shingles after having the shot were probably given the live virus (the patient stated this makes sense).  The patient experienced shingles in last June 2021. The patient further stated that the patient would not with them on his/her worst enemy. No mention of any future boosters. The patient put off himself /herself getting the shot as several patient's experienced shingles after getting shot.  The patient stated no mention of any future boosters. This case was considered as suspected vaccination failure, since the details regarding the laboratory confirmation for shingles were not provided. This case has been linked with US2021AMR178376, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR178376:Same reporter
sore arm, & tiredness; sore arm, & tiredness; This is a spontaneous report from a contactable consumer or other non hcp.     An 80-years-old male patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 13Feb2021 as dose 1, single for covid-19 immunisation.The patient medical history and concomitant was not reported. It was Reported that, the patient experienced sore arm, & tiredness on an unspecified date with outcome of unknown.    Information about lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
This spontaneous report was received from a registered nurse refers to unspecified patients of unknown age and sex. On an unspecified date beginning in August 2015 and continued through October 2015, unspecified number of patients were vaccinated with improperly stored PEDVAXHIB (lot # J015437 and expiry 09-OCT-2016). Concomitant medications were not reported. No symptoms were reported. No PQC were involved. This is one of the several reports from the same source. Additional information has been requested.
I had a fast heart rate (approx 120 beats per minute while resting). I called my consulting nurse who advised me to go into Urgent Care. I went to Urgent Care. They gave me an EKG, which showed my increased heart rate, but nothing abnormal. I was given Tylenol to see if that decreased my heart rate, but it didn't. I was told to drink lots of water to see if dehydration might be why my heart rate was increased. The Urgent Care doctor consulted with an OB Doctor and concluded that my increased heart rate was due to my body's response to the vaccine in connection with the pregnancy.   At the time of the adverse event, I was 23 weeks pregnant. My estimated date of delivery is July 13, 2021. This current pregnancy is my 3rd. My second pregnancy ended in a miscarriage. During my first pregnancy, I developed Gestational Diabetes and Preeclampsia. I needed insulin to manage the Gestational Diabetes and I was induced at 37 weeks pregnant because of the Preeclampsia. My daughter had to be in the NICU after birth for 5 days due to low oxygen, low blood sugar, low muscle tone, dusky color, and no cry.
pt recv vax & c/o diff swallowing & itching inside mouth & throat 3 days post vax;pt states sx resolved overnight & did not seek medical tx;since that time lt tricep (inoculation site) has become swollen, itchy & red;
Extremely swollen and painful lymph glands located on L side collar bone.  Same lymph glands became swollen 5 days after 1st injection and Dr. wanted to me to report them and I did. This time the morning after the injection the glands were extremely swollen so much so that my coworkers could see them on my collar bone.  I also had with the 2nd vaccinatation fever, chills, headache and fatigue that I considered a normal reaction.
w/in 12 hrs of vax pt became ill w/body aches, temp, n&v; this went on for several wks off & on; w/in 1 wk devel petechial type rash mostly dependent w/swelling of lower extremities & mild effusion to knees; tension type h/a x 1 mo;
Information has been received on 15-AUG-2017 regarding a case in litigation from a lawyer and a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported. The patient was inoculated with ZOSTAVAX (lot number and expiration not reported) subcutaneous in 2011 at a drugstore as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. Throughout the years of 2013 and 2015, the patient was treated by a physician for the onset of a severe vesicular eruption accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. Throughout the years of 2013 and 2015, the patient was also treated by another physician at a medical clinic for ongoing and worsening symptoms of shingles. As a direct and proximate result of these malfunctions the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.